REXAHN PHARMACEUTICALS, INC. 4
4 · REXAHN PHARMACEUTICALS, INC. · Filed Jun 13, 2007
Insider Transaction Report
Form 4
McIntosh David M
Director
Transactions
- Award
Stock Option (Right to Buy)
2007-06-11+20,000→ 20,000 totalExercise: $1.40From: 2008-06-11Exp: 2017-06-11→ Common Stock (20,000 underlying)
Holdings
- 125,000
Stock Option (Right to Buy)
Exercise: $0.80Exp: 2014-04-20→ Common Stock (125,000 underlying) - 20,000
Stock Option (Right to Buy)
Exercise: $3.00From: 2006-09-12Exp: 2015-09-12→ Common Stock (20,000 underlying)
Footnotes (2)
- [F1]Options fully vest on the first anniversay of the date of grant.
- [F2]30% of the options vested and became exercisable on April 20, 2005; another 30% of the options vested and became exercisable on April 20, 2006; and the remaining 40% of the options vested and became exercisable on April 20, 2007.